Navigation Links
3SBio Inc. Schedules Unaudited Fourth Quarter and Full Year 2012 Results
Date:3/3/2013

SHENYANG, China, March 3, 2013 /PRNewswire/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it will release its unaudited fourth quarter and full year 2012 results on Tuesday, March 19, 2013 at 8:00am China Standard Time.

Following the earnings announcement, 3SBio's senior management will host a conference call on Tuesday, March 19, 2013 8:00pm China Standard Time (8:00am US Eastern or 5:00am US Pacific) to discuss its unaudited fourth quarter and full year 2012 results and recent business activity. The conference call may be accessed using the dial-in numbers below:

Conference ID: 15890708

Local dial-in:
China landline: 800-819-0121
China mobile: 400-620-8038
Hong Kong : 852-2475-0994
United States: 718-354-1231

International toll-free dial-in:
Hong Kong: 800930346
United States: 1-866-519-4004
United Kingdom: 080-8234-6646

International toll dial-in: 65 6723 9381

Replay- Conference ID: 15890708
A telephone replay will be available two hours after the call until March 27, 2013 at:
International: 61-2-8235-5000
United States: 1-866-214-5335

Webcast
A live webcast of the conference will be available on the investor relations section of 3SBio's website at www.3sbio.com and at http://www.media-server.com/m/p/bcshv7v5.

A replay of the webcast will be available within one hour after the conclusion of the call.

About 3SBio Inc.3SBio is a leading, fully integrated, profitable biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China. Its focus is on addressing large markets with significant unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases. With headquarters and GMP-certified manufacturing facilities in Shenyang, PRC, 3SBio employs over 800 people. Shares trade in the form of American Depositary Shares (ADSs) on the NASDAQ stock market under the ticker symbol "SSRX". Please see www.3SBio.com for more information. Investor ContactsBo Tan

Tom FolinsbeeChief Financial Officer

Director of Investor Relations3SBio Inc.

3SBio Inc. Tel: + 86 24 2581-1820

Tel: + 852 8191-6991  ir@3SBio.com

ir@3SBio.com


'/>"/>
SOURCE 3SBio Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. 3SBio Inc. Announces Unaudited Third Quarter 2012 Results
2. 3SBio Independent Committee Selects Legal Counsel in connection with Going Private Proposal
3. 3SBio Inc. Announces Receipt of "Going Private" Proposal at $15 Per ADS
4. 3SBio Inc. to Hold 2012 Annual General Meeting on October 10, 2012
5. Apexigen Announces the Filing of an IND by its Partner, 3SBio
6. 3SBio Inc. Announces Changes to Its Board of Directors
7. 3SBio Inc. Schedules Unaudited Second Quarter 2012 Results
8. 3SBio Obtains SFDA Approval to Join Global Phase III Trial for Voclosporin
9. 3SBio Inc. To Present at the DB Access Asia Conference 2012
10. 3SBio Inc. Schedules Unaudited First Quarter 2012 Results
11. GSI Group Inc. Schedules Earnings Release and Conference Call for Tuesday, March 12, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... Feb. 21, 2017  /PR Newswire/ -- UBM Medica,s ... announce the launch of Modern Retina ( ... retina specialists. Built upon the success of ... on the latest innovations in the areas of retinal ... management. By meeting current informational needs and filling existing ...
(Date:2/21/2017)... , Feb. 21, 2017   BeyondSpring ... on the development of innovative immuno-oncology cancer therapies, ... significant data from its Phase 2 trial of ... the treatment of non-small cell lung cancer (NSCLC) ... at this year,s ASCO-SITC Clinical Immuno-Oncology Symposium in ...
(Date:2/21/2017)... IDAHO FALLS, Idaho , Feb. 21, 2017 /PRNewswire/ ... is has completed a private placement with certain investors ... preferred stock of the Company, Series C Convertible Redeemable ... Stock accrues dividends at an annual rate of 6% ... share.  The Company plans to use the proceeds for ...
Breaking Medicine Technology:
(Date:2/21/2017)... ... 21, 2017 , ... Hanna Boys Center http://www.hannacenter.org ... the keynote speaker at its second Professional Networking Breakfast on March 9, 2017. ... comprehensive strategies to create and expand opportunities for boys and young men of ...
(Date:2/21/2017)... ... February 21, 2017 , ... As recently as 2015, rhinoplasty was one of ... of Plastic Surgeons. Some patients want to make a change in the appearance of ... their breathing ability. The team at usrhinoplasty.org is expanding its article database ...
(Date:2/21/2017)... (PRWEB) , ... February 21, 2017 , ... Ray Insurance ... communities in and around Tarrant County, is embarking on a six month charity event ... and treatments for cancer. , Cancer is one of the deadliest diseases in America; ...
(Date:2/21/2017)... ... February 21, 2017 , ... American Veterinarian™, the premier multimedia ... launching its first bi-monthly issue of 2017 in February. The inaugural issue will ... One Health. , In making the announcement, American Veterinarian™ Publisher Chris Hennessy ...
(Date:2/21/2017)... ... 2017 , ... Each February the nation reflects upon African ... American History Month ). This month-long celebration encourages reflection upon the ... people, but also the opportunity to examine the trends of addiction among African ...
Breaking Medicine News(10 mins):